Free Republic
Browse · Search
News/Activism
Topics · Post Article

Skip to comments.

Cell-sized vesicle assembly line
Chemistry World ^ | 04 August 2009 | Nina Notman

Posted on 08/04/2009 10:50:54 PM PDT by neverdem

A production line for uniform lipid-coated microspheres has been created by Japanese scientists. Using a microfluidic device, the team can continuously generate fluid-filled vesicles that are all the same size and all have a single lipid bilayer surrounding them, and could one day be used in drug delivery or artificial cells. 

Whilst lipid vesicles are used widely, problems with current production methods mean it is difficult to ensure they are all uniform in size and there is just one lipid bilayer surrounding each vesicle. Another tricky issue is developing an efficient encapsulation process, making sure the vesicle contents aren't lost during synthesis. 

Shoji Takeuchi and colleagues at the University of Tokyo claim to be the first to have devised a route that overcomes all three of these hurdles. 'These features have not been accomplished simultaneously with the other routes,' says Takeuchi.

The team's high-throughout production method uses a microfluidic device consisting of a main channel lined with small chambers. To prepare the device, it is first filled with an aqueous solution containing the material that will make up the vesicles' contents. Oil is then flowed through the device's main channel. This washes the aqueous solution out of the channel, trapping the water in the chambers where a monolayer forms at the interface of the oil and water. The aqueous solution then re-enters the main channel, replacing the oil and pushing some of it down into the top of each of the chambers. A layer of lipid forms here, squashed between the two aqueous layers, with a monolayer at both the 'water'-oil interfaces.

Next, a continuous stream of another aqueous solution is pushed through the main channel, and a gentle flow of the original aqueous solution allowed to enter from bottom of each of the chambers. The flow across the chamber entrance combined with the gentle flow upwards from bottom of the chamber causes the lipid layer to thin out, and the two monolayers to form one bilayer. The shear force combined with the upwards flow of aqueous solution means the lipid bilayer is pulled/pushed up into the fast flowing stream of aqueous solution in the device's main channel. The shear force of the flow on the deformed bilayer eventually leads to a vesicle being pulled off from the leading edge of the bilayer. This process then continues, releasing 'perfectly' sized and shaped vesicles at regular intervals (see image and video).

Microfluidic production line

Microfluidic production line for uniform size vesicles with a single lipid bulayer

© Angew. Chem. Int. Ed.

One bilayer produces 50 to 100 vesicles, and with multiple chambers in the main channel each device can produce thousands of vesicles at a rate of several hundred vesicles per minute. The device currently only works for a limited period (until the lipid bilayer runs out), but the researchers say that they should be able to scale up the process by making the lipid layer at the top of each chamber thick enough to make several thousand vesicles per chamber.  

Jonathan Howse, an expert in making polymer vesicles at the University of Sheffield in the UK, is impressed by the work. 'It is like blowing bubbles underwater,' he says, 'a bubble from a child's toy is just a bubble of air, trapped by a liquid layer, in air, and this is a volume of water trapped inside a lipid layer in water. The lipid layer is analogous to the toy that you blow through.' He particularly likes the fact that the aqueous solution that is encapsulated is separate from the medium flowing through the device at all times - giving the process high encapsulation efficiency.  

Currently the device only produces vesicles of one size, approximately cell-sized. This makes it useful for artificial cell research, according to Takeuchi. The vesicles have a phospholipid membrane, analogous with living cells, and can be used to model the kinetic behaviour of living cells and for drug delivery applications. 'We now need to study how our immune system will respond to our vesicles,' says Takeuchi. 'Since we use oil (hexadecane) to form the lipid bilayer and this oil remains inside the membrane, we need to know how this remaining oil affects [human bodies] compared to oil-free vesicles,' he adds.  

In terms of adapting the concept to produce different sized vesicles for other applications, Takeuchi told Chemistry World that  it might be difficult to generate different size vesicles from the current device. 'But we may be able to change the dimensions of the device and generate different size vesicles with different contents for various purposes,' he adds.

 

References

A Ota, S Yoshizawa and S Takeuchi, Angew. Chem. Int. Ed., 2009, DOI: 10.1002/anie.200902182

Also of interest

Islands in a non-stick sea

Non-stick approach to regular polymer vesicles

17 May 2009

By being confined to small islands in a 'non-stick' sea, self-assembling polymers can form into uniform vesicles of a pre-determined size



TOPICS: Culture/Society; News/Current Events; Technical
KEYWORDS: assembly; cellsized; drugdelivery; medicine; microfluidics; vesicle; vesicleassembly
There's a silly video at the source.
1 posted on 08/04/2009 10:50:55 PM PDT by neverdem
[ Post Reply | Private Reply | View Replies]

To: neverdem

I charge this article with vesicular manslaughter.


2 posted on 08/04/2009 10:55:31 PM PDT by rfp1234
[ Post Reply | Private Reply | To 1 | View Replies]

To: neverdem
Liposomes are proving to be very useful as a drug delivery tool. For example, Doxorubicin is a toxic chemotherapy drug can be delivered at lower doses using liposomes as the targeted drug delivery vehicle, thus providing more medical benefit with less toxicity. This is cool stuff!
3 posted on 08/04/2009 11:04:31 PM PDT by Left2Right ("Starve the Beast!")
[ Post Reply | Private Reply | To 1 | View Replies]

To: neverdem

do these vesicles qualify to the clunker deal?


4 posted on 08/04/2009 11:09:36 PM PDT by the invisib1e hand (The revolution IS being televised.)
[ Post Reply | Private Reply | To 1 | View Replies]

To: the invisib1e hand
for the clunker deal, that is.

Ahh, fuggedaboudit.

5 posted on 08/04/2009 11:10:03 PM PDT by the invisib1e hand (The revolution IS being televised.)
[ Post Reply | Private Reply | To 4 | View Replies]

To: Left2Right
Can they make an SUV Assembly Line?

(excerpt) Liposome Structure Liposomes have different morphologies based upon their composition and the formulation method. Formulations frequently used for the delivery of nucleic acids are small unilamellar vesicles (SUVs), multilamellar vesicles (MLVs), or bilamellar invaginated structures (BIVs).

SUVs condense nucleic acids on the surface and form "spaghetti and meatballs" structures (Sternberg, 1996). DNA:liposomal complexes made using SUVs produce little or no gene expression upon systemic delivery, although these complexes transfect numerous cell types efficiently in vitro (Felgner et al., 1987; Felgner et al., 1994).

http://www.pharmcast.com/Patents100/Yr2006/May2006/050206/7037520_Liposome050206.htm

6 posted on 08/04/2009 11:23:27 PM PDT by rfp1234
[ Post Reply | Private Reply | To 3 | View Replies]

To: neverdem

That’s nothing; my children have a device for producing uniformly sized gas filled spheres of hydrated bi-lipids that just positively drive the family dog crazy.


7 posted on 08/05/2009 3:18:44 AM PDT by Born to Conserve
[ Post Reply | Private Reply | To 1 | View Replies]

To: Left2Right
I studied liposomes 25 years ago when they were The Next Big Thing. Still lots of hoopla and very few practical applications.

Cool yes, useful? hardly.

8 posted on 08/05/2009 6:27:48 AM PDT by corkoman
[ Post Reply | Private Reply | To 3 | View Replies]

To: Left2Right
For example, Doxorubicin is a toxic chemotherapy drug can be delivered at lower doses using liposomes as the targeted drug delivery vehicle, thus providing more medical benefit with less toxicity. This is cool stuff!

IIRC, I mixed Doxorubicin for the nurses as an intern. Is Doxorubicin given by liposomes now?

9 posted on 08/05/2009 10:55:22 AM PDT by neverdem (Xin loi minh oi)
[ Post Reply | Private Reply | To 3 | View Replies]

To: neverdem
"Is Doxorubicin given by liposomes now?"

Check out the Doxil web page. Fascinating stuff. I think they may even by trying to add targeted proteins to the outside of the liposomes, although as I understand it that is problematic since cancer cells tend to mutate and render the targeted proteins useless. I'm not sure how they get the Doxorubicn in the liposome:

DOXIL Web Page

10 posted on 08/06/2009 10:04:58 AM PDT by Left2Right ("Starve the Beast!")
[ Post Reply | Private Reply | To 9 | View Replies]

To: Left2Right

Thanks for the link.


11 posted on 08/06/2009 10:38:16 AM PDT by neverdem (Xin loi minh oi)
[ Post Reply | Private Reply | To 10 | View Replies]

Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.

Free Republic
Browse · Search
News/Activism
Topics · Post Article

FreeRepublic, LLC, PO BOX 9771, FRESNO, CA 93794
FreeRepublic.com is powered by software copyright 2000-2008 John Robinson